hypothyroidism can affect cardiac contractility, and low free T3 levels are associated with increased mortality in patients with heart disease. [6] Echocardiography is an imaging technique which provides information about the structure and function of the heart. Structural abnormalities, systolic dysfunction, diastolic dysfunction, or a combination of these abnormalities are commonly seen in patients with heart disease. According to ACC/AHA as well as ESC guidelines, echocardiography is the single most useful test in the diagnosis of heart failure. It accurately and noninvasively provides objective evidence of structural or functional abnormalities which explain a patient's symptoms of heart failure. Echocardiography is also able to identify the hemodynamic and morphologic changes in HF over time and is therefore considered an indispensable tool in the management of heart failure. [7, 8] However, there are limited data regarding the association of echocardiographic findings and comorbidities in CHF patients. This information could have clinical benefits for screening as well as for planning preventive therapies to avoid progression of the disease. Hence, the current study was designed to evaluate the association between echocardiographic findings and comorbidities in CHF patients in India.
Methodology
This was a retrospective study conducted by collecting data of CHF patients who had visited one of the Madhavbaug clinics in the state of Maharashtra in India. Patients had to have been seen at the clinic between July 2018 and December 2018 to be considered for inclusion. The case records of CHF patients attending the clinic in the desired time period were screened for the presence of baseline details relevant to the objective of this study and for the presence of two-dimensional echocardiography (2D echo) results with assessment of left ventricular ejection fraction (LVEF). Data of only those patients whose baseline demographic data, details about comorbidities, and LVEF were present in the case records were included. The study conforms to the national medical research ethics and it was approved by the relevant departments.
Data entry was completed in a Microsoft Excel sheet. GraphPad InStat software V3.0 (San Diego, California, GraphPad Software) was used to analyze the noted data. The patients were classified based on normal (>55%) and compromised (<55%) LVEF. The patients were also classified based on grades of diastolic dysfunction: Grade I -impaired relaxation, Grade II -pseudonormal, and Grade III -reversible restrictive. [9] Categorical data were shown in numerical form, whereas continuous data were noted as mean ± standard deviation. To assess the association between comorbidities and findings on echocardiography (ejection fraction and diastolic dysfunction), Chi-square test was used. Data from Chi-square testing were presented as odds ratio (OR) with 95% confidence interval (CI). P < 0.05 was considered statistically significant.
Results
One hundred and thirty-eight patients who consulted the Madhavbaug clinics within the specified study period met the screening inclusion criteria of the study. The data of all included patients were noted accordingly and are presented in Table 1 . Included patients were predominantly male (n = 109, 74.15%). The mean age of patients enrolled in this study was found to be 59.15 ± 10.28 years.
The echocardiographic findings of these 138 CHF patients were noted, and mean values were calculated. It was found that the mean LVEF for the CHF patients was 51.32% ± 12.53%. Of these 138 patients, 45% of patients had compromised LVEF, whereas 55% of patients had LVEF within the normal range [ Table 2 ]. Figure 1a -d is a representative image of a 2D echo taken at the study center.
The grade-wise distribution of patients with diastolic dysfunction is presented in Table 3 . About 57.89% of patients were observed to have Grade I diastolic dysfunction, whereas 39.84% of patients had Grade II or worse diastolic dysfunction.
Subgroup analyses testing the association between echocardiographic ejection fraction groups and comorbidities of CHF are shown in Subgroup analyses testing the association between diastolic dysfunction groups and comorbidities of CHF are shown in 
discussioN
Most of the symptoms observed in patients with CHF are associated with the presence of comorbidities such as CAD, HTN, DM, ischemic heart disease, obesity, dilated cardiomyopathy, myocardial infarction, and hypothyroidism. These comorbidities have an impact on hospitalizations and are associated with mortality in patients with CHF. [10, 11] CAD is one of the leading comorbidities observed in patients with CHF. The data suggest that ischemic cardiomyopathy is believed to be the primary etiology in 41% of CHF patients. [12] Dilated cardiomyopathy is the second most common cardiac comorbidity seen in patients with CHF. It is attributed to about 25% of chronic heart failure patients. [5] HTN itself has a strong impact on the progression of CHF and is a key factor in the development of left ventricular hypertrophy and diastolic dysfunction seen in patients with CHF. [13] Extracardiac comorbidities such as DM affect ventricular structure and function through various mechanisms. In DM, various factors such as glycosylated end-product formation, impaired endothelial function, sympathetic nervous system activation, and derangements in myocardial metabolism lead to diabetic cardiomyopathy. [14] Thyroid hormones also play an important role in heart failure. In heart failure, the conversion of T4 to T3 decreases. Since T3 is the main regulator of gene expression in myocardial muscle, this decrease has been thought to affect myocardial contractility and remodeling. [15] Looking at this background, it is obvious that comorbidities have a role in the pathology of CHF. They strongly influence outcomes, and hence, a diagnostic tool is needed to help predict the course of the disease. One such diagnostic intervention is echocardiography which can assess myocardial structure and function, valvular disease, and hemodynamics and is considered an indispensable tool for the diagnosis of CHF. One of the important parameters measured using echocardiography is LVEF. It plays a pivotal role in the management of CHF as it helps to identify patients who are likely to respond to therapy for HF with reduced EF. Another such important entity which can be measured with echocardiography is diastolic function of the heart. Diastolic dysfunction is an important etiological factor in patients of heart failure with preserved ejection fraction and no structural abnormalities. It is categorized into mild or Grade I (delayed relaxation), moderate or Grade II (pseudonormal), and severe or Grade III (restrictive) dysfunction. These parameters help physicians to choose prognostically beneficial therapy for CHF. [16] The authors felt a need to know whether these echocardiographic findings are associated with comorbidities of CHF, the knowledge of which would help in better predicting prognosis of the disease. A retrospective analysis of the data collected from CHF patients in India suggested that majority of the patients were male in the age group of 59 years. These findings are in sync with the published demographic statistics that CHF is a disease of the elderly. [10] Most of the patients in the current study had preserved/normal ejection fraction, but 45% had compromised ejection fraction, whereas the majority of patients also had Grade I diastolic dysfunction.
Subgroup analyses suggested that patients with CAD, myocardial infarction, and ischemic cardiomyopathy had higher odds of compromised ejection fraction than those with normal ejection fraction. Similarly, HTN was associated with higher odds of Grade I diastolic dysfunction, compared with Grade II and III diastolic dysfunction. A study by Streng et al. showed similar findings with many comorbidities showing associations with compromised ejection fraction. [17] A study by Anand et al. studied similar risk factors but had contradictory findings. [18] The findings of that study suggest that morbid obesity, CAD, DM, and HTN were associated with increased odds of having heart failure of preserved ejection fraction. However, neither of these prior studies studied risk factors for diastolic dysfunction.
Our study had a few limitations. The sample size was small and restricted to the CHF patients of West India. Future prospective studies with larger sample size representative of the whole country will help in creating more robust evidence.
coNclusioNs
Patients with comorbidities such as CAD, dilated cardiomyopathy, ischemic cardiomyopathy, and myocardial infarction have higher odds of compromised ejection fraction, whereas patients with HTN have higher odds of Grade I diastolic dysfunction. These findings should help physicians in planning preventive therapies to avoid progression of the disease.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest. 
